CoChat

Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer

Nesbitt, Heather, Sheng, Yingjie, Kamila, Sukanta, Logan, Keiran, Thomas, Keith, Callan, Bridgeen, Taylor, Mark A., Love, Mark, O'Rourke, Declan, Kelly, Paul, Beguin, Estelle, Stride, Eleanor, McHale, Anthony P., Callan, John F. · 2018 · Journal of Controlled Release
Cited by 108

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Pancreatic cancer remains one of the most lethal forms of cancer with a 10‐year survival of <1%. With little improvement in survival rates observed in the past 40years, there is a significant need for new treatments or more effective strategies to deliver existing treatments. The antimetabolite gemcitabine (Gem) is the most widely used form of chemotherapy for pancreatic cancer treatment, but is known to produce significant side effects when administered systemically. We have previously demonstrated the benefit of combined chemo‐sonodynamic therapy (SDT), delivered using oxygen carrying microbubbles (O2MB), as a targeted treatment for pancreatic cancer in a murine model of the disease. In this manuscript, we report the preparation of a biotin functionalised Gem ligand for attachment to O2MBs (O2MB‐Gem). We demonstrate the effectiveness of chemo‐sonodynamic therapy following ultrasound‐targeted‐microbubble‐destruction (UTMD) of the O2MB‐Gem and a Rose Bengal loaded O2MB (O2MB‐RB) as a targeted treatment for pancreatic cancer. Specifically, UTMD using the O2MB‐Gem and O2MB‐RB conjugates reduced the viability of MIA PaCa‐2, PANC‐1, BxPC3 and T110299 pancreatic cancer cells by >60% (p<0.001) and provided significant tumour growth delay (>80%, p<0.001) compared to untreated animals when human xenograft MIA PaCa‐2 tumours were treated in SCID mice. The toxicity of the O2MB‐Gem conjugate was also determined in healthy non‐tumour bearing MF1 mice and revealed no evidence of renal or hepatic damage. Therefore, the results presented in this manuscript suggest that chemo‐sonodynamic therapy using the O2MB‐Gem and O2MB‐RB conjugates, is potentially an effective targeted and safe treatment modality for pancreatic cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2018.04.018

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 108

Metadata

Authors
Nesbitt, H., Sheng, Y., Kamila, S., Logan, K., Thomas, K., Callan, B., Taylor, M. A., Love, M., O'Rourke, D., Kelly, P., Beguin, E., Stride, E., McHale, A. P., & Callan, J. F.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2018-06
Volume
279
Pages
8-16
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2797148094
Cited by
108
References
5
FWCI
5.47
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.